'''3',4'-Methylenedioxy-α-pyrrolidinobutyrophenone''' ('''MDPBP''') is a [[stimulant]] of the [[substituted cathinone|cathinone]] class developed in the 1960s,<ref>{{citation|first1=Koeppe|last1=Herbert|first2=Zeile|last2=Karl|first3=Ludwig|last3=Gerhard|title=Patent DE1545591 - Verfahren zur Herstellung von α-Aminoketonen mit heterocyclischer Aminogruppe|url=https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19690807&DB=&locale=en_EP&CC=DE&NR=1545591A1&KC=A1|date=28 May 1965|language=de}}</ref><ref>{{cite journal|first1=Renata|last1=Kolanos|first2=Ernesto|last2=Solis|first3=Farhana|last3=Sakloth|first4=Louis J. De|last4=Felice|title="Deconstruction" of the Abused Synthetic Cathinone Methylenedioxypyrovalerone (MDPV) and an Examination of Effects at the Human Dopamine Transporter|journal=ACS Chemical Neuroscience|date=18 December 2013|pages=1524–1529|volume=4|issue=12|pmid=24116392|pmc=3867964|doi=10.1021/cn4001236|first5=Richard A.|last5=Glennon}}</ref> which has been reported as a novel [[designer drug]].<ref>{{cite journal|first1=Folker|last1=Westphal|first2=Thomas|last2=Junge|first3=B.|last3=Klein|first4=Giselher|last4=Fritschi|title=Spectroscopic characterization of 3,4-methylenedioxypyrrolidinobutyrophenone: A new designer drug with α-pyrrolidinophenone structure|url=http://www.sciencedirect.com/science/article/pii/S0379073811000296|journal=Forensic Science International|date=15 June 2011|pages=126–132|volume=209|issue=1–3|doi=10.1016/j.forsciint.2011.01.016|pmid=21316166|first5=Ulrich|last5=Girreser}}</ref><ref>{{cite journal|first1=Marek|last1=Wiergowski|first2=MateuszK.|last2=Woźniak|first3=Marzena|last3=Kata|first4=Marek|last4=Biziuk|title=Determination of MDPBP in postmortem blood samples by gas chromatography coupled with mass spectrometry|journal=Monatshefte für Chemie - Chemical Monthly|date=August 2016|issn=0026-9247|pages=1415–1421|volume=147|issue=8|pmid=27546909|pmc=4971041|doi=10.1007/s00706-016-1780-0}}</ref> MDPBP is sometimes sold under the name "NRG-1" as a mixture with other cathinone derivatives, including [[flephedrone]], [[pentylone]], [[4'-Methyl-α-pyrrolidinopropiophenone|MαPPP]] and its higher homologue [[Methylenedioxypyrovalerone|MDPV]].<ref>{{cite journal|first1=Simon D.|last1=Brandt|first2=Sally|last2=Freeman|first3=Harry R.|last3=Sumnall|first4=Fiona|last4=Measham|title=Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones|url=http://onlinelibrary.wiley.com/doi/10.1002/dta.204/abstract|journal=Drug Testing and Analysis|date=September 2011|issn=1942-7611|pages=569–575|volume=3|issue=9|doi=10.1002/dta.204|pmid=21960541|first5=Jon|last5=Cole}}</ref> As with other [[substituted cathinones|cathinones]], MDPBP has been shown to have reinforcing effects in rats.<ref>{{cite journal|last1=Gannon|first1=BM|last2=Galindo|first2=KI|last3=Mesmin|first3=MP|last4=Sulima|first4=A|last5=Rice|first5=KC|last6=Collins|first6=GT|title=Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.|journal=Neuropharmacology|date=12 August 2017|doi=10.1016/j.neuropharm.2017.08.018|pmid=28811192}}</ref>
